市場調查報告書

細胞培養的南美市場:分析與預測 (2018-2025年)

Latin America Cell Culture Market: Focus on Product Types (Consumables and Instruments), End Users, Country Data (5 Countries), and Competitive Landscape: Analysis and Forecast, 2018-2025

出版商 BIS Research Inc. 商品編碼 816189
出版日期 內容資訊 英文 173 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
細胞培養的南美市場:分析與預測 (2018-2025年) Latin America Cell Culture Market: Focus on Product Types (Consumables and Instruments), End Users, Country Data (5 Countries), and Competitive Landscape: Analysis and Forecast, 2018-2025
出版日期: 2019年03月26日內容資訊: 英文 173 Pages
簡介

本報告提供南美的細胞培養市場相關調查,市場成長的主要的促進因素、課題、機會,在市場中帶來新的趨勢的基本結構,各市場區隔的成長預測和收益預測,在先進、新興地區的主要法規的影響,主要企業,及各國市場分析等彙整資料。

第1章 市場概要

  • 細胞培養技術
  • 細胞培養歷史性的展望
  • 南美的細胞培養市場分類
  • 市場足跡
  • 南美的細胞培養市場未來的可能性

第2章 市場動態

  • 概要
  • 冰山分析
  • 影響分析
  • 市場成長的促進因素
  • 市場成長的阻礙因素
  • 市場機會

第3章 競爭環境

  • 主要策略、發展
  • 市場佔有率分析
  • 成長佔有率分析 (機會製圖)
  • 產業的魅力

第4章 南美的細胞培養市場:各產品

  • 概要
  • 消耗品
  • 設備

第5章 南美的細胞培養市場:各終端用戶

  • 概要
  • 生物科技、生命科學企業
  • 醫藥品企業
  • 大學、研究機關

第6章 南美的細胞培養市場:各國

  • 概要
  • 巴西
  • 墨西哥
  • 阿根廷
  • 智利
  • 哥倫比亞
  • 其他南美

第7章 企業簡介

  • 概要
  • Becton, Dickinson and Company
  • CellGenix GmbH
  • Corning Incorporated
  • Eppendorf AG
  • FUJIFILM HOLDINGS CORPORATION
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

第8章 調查範圍、調查手法

目錄
Product Code: BH122B

Latin America Cell Culture Market, by Product to Reach $1.09 Billion by 2025

Cell culture has been dubbed as the integral 'work-horse' for any biopharmaceutical manufacturing process. With an integral role in the cultivation of artificial organs, for the development of cells to test antibiotics against, and for research purposes that delve deep into the understanding of the effect of disease causing organisms within the human body, the cell culture market is consistently growing as a result of the expanding healthcare market. Recent trends with regard to extensive government support through funding for the promotion of regenerative medicine in the region is significantly propelling the market. Also, owing to ensuing increase in disposable income in major countries such as Brazil and Mexico, the regional cell culture market is witnessing a massive influx of technological trends that have already become routine in the global cell culture market. With the Latin America region posing as one of the lesser-developed regions with respect to the medical advancements that have become routine in other parts of the world, there is immense potential for growth of the Latin America cell culture market.

The purpose of the study is to gain a holistic view of Latin America cell culture market in terms of various factors, including regulatory reforms and technological advancements, which are influencing the market. The market has been segmented into 'product', 'end user', and 'country'. The scope of this report is centered upon conducting a detailed study of the products allied with the Latin America cell culture market. In addition, the study also includes the exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of companies, as well as other vital information with respect to Latin America cell culture market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the Latin America cell culture market with the help of the key factors driving the market, the restraints, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter's Five Forces for a comprehensive understanding of the Latin America cell culture market. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple countries, growth of Latin America cell culture market in each country, and the key strategies and developments by the prominent manufacturers.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges, and opportunities in the Latin America cell culture market?
  • What are the underlying structures resulting in the emerging trends within the Latin America cell culture market?
  • How will each segment of the Latin America cell culture market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
  • What are the key regulatory implications in developed and developing regions for the Latin America cell culture market?
  • Who are the leading players with significant offerings to the Latin America cell culture market? What is the current market dominance for each of these leading players?
  • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2018-2025? Which cell culture product type is having the most promising growth?
  • Who are the primary end users in the Latin America cell culture market? Which is the fastest growing end-use segment in the Latin America cell culture market?
  • Who are the key manufacturers in the Latin America cell culture market, and what are their contributions? Also, what is the growth potential of each major cell culture products manufacturer?
  • What is the scope of the Latin America cell culture market in Brazil, Argentina, Mexico, Chile, and Colombia?

The key manufacturers who have been contributing significantly to the global industrial microbiological QC market include Becton, Dickinson and Company, CellGenix GmbH, Corning Incorporated, Eppendorf AG, Fujifilm Holdings Corporation, General Electric Company, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., among others.

Executive Summary

Although a mature market, the cell culture market is consistently witnessing significant evolution in the technological developments it has given rise to. With respect to organ transplantation and study of the disease mechanism in human, the concept of 3D cell culture has defined the current era. This type of cell culture not only allows for better visualization of the environment within the human body, but there is also the aspect of realizing the instantaneous effects of a wide variety of agents in real-time. Another largely undermined factor for the rising global disease burden is antimicrobial resistance (AMR). Largely a natural phenomenon, antimicrobial resistance is triggered by the excess usage of antibiotics for treatment of diseases with microbial origins. A complex issue of global concern, AMR is majorly driven by human action and perverse incentives. AMR has been synonymous with the promotion of drug discovery and novel molecule discovery.

The predominant aspect of cell culture is the integral for any biopharmaceutical manufacturing process. Also, cell culture plays an integral role in the cultivation of artificial organs, for the development of cells to test antibiotics against, and for research purposes that delve deep into the understanding of the effect of disease causing organisms within the human body. With the Latin America region posing as one of the lesser-developed regions with respect to the medical advancements that have become routine in other parts of the world, there is immense potential for growth of the Latin America cell culture market.

The Latin America cell culture market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.20% during the forecast period, 2018-2025. Growing at the fastest CAGR of 6.48% during the forecast period of 2018-2025, the consumables segment is anticipated to generate a value of $811.5 million in 2025.

The purpose of the study is to gain a holistic view of the Latin America cell culture market in terms of various factors, such as recent trends and product advancements, influencing the market. The scope of this report is centered upon conducting a detailed study of the products allied with the Latin America cell culture market, broadly classified as consumables and instruments. However, the market estimation only comprises manufacturers of these products. The Latin America cell culture market is segmented into three different segments namely product, end user, and country. These segments are further segmented into several sub-segments to ease the market estimation and to gain a holistic view of the market. The overall market value was estimated using different approaches and validated with each other.

Based on countries, the Latin America cell culture market is segmented into Brazil, Mexico, Argentina, Chile, and Colombia, which have been studied and documented in detail to understand the various factors that are consistently responsible for shaping up the market.

The key manufacturers who have been contributing significantly to the Latin America cell culture market include Becton, Dickinson and Company, CellGenix GmbH, Corning Incorporated, Eppendorf AG, Fujifilm Holdings Corporation, General Electric Company, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., among others.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Cell Culture Technology
  • 1.2 Historical Perspective of Cell Culture
  • 1.3 Classification of Latin America Cell Culture Market
  • 1.4 Market Footprint
  • 1.5 Future Potential of the Latin America Cell Culture Market

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Iceberg Analysis
  • 2.3 Impact Analysis
  • 2.4 Market Drivers
    • 2.4.1 Increasing Incidence of Infectious Diseases Pressurizes Increasing Drug Discovery
    • 2.4.2 Growing Demand for Monoclonal Antibodies (mAbs)
    • 2.4.3 Growing Availability of Advanced Media Solutions
    • 2.4.4 Increasing Government-funding for Cell-based Research
  • 2.5 Market Restraints
    • 2.5.1 Concerns for Scalability of Process
    • 2.5.2 Ethical Concerns in the Production of Cell Culture Media
    • 2.5.3 Lack of Skilled Personnel for Proper Handling of Culture Media
  • 2.6 Market Opportunities
    • 2.6.1 Insurgence of 3D Cell Cultures
    • 2.6.2 Escalating Cases of Severe Chronic Diseases that Require Organ Transplantation

3 Competitive Landscape

  • 3.1 Key Strategies and Developments
    • 3.1.1 Product Launches and Enhancements
    • 3.1.2 Synergistic Activities
    • 3.1.3 Acquisitions, Approvals, and Expansion Activities
  • 3.2 Market Share Analysis
  • 3.3 Growth Share Analysis (Opportunity Mapping)
  • 3.4 Industry Attractiveness
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Threat of New Entrants
    • 3.4.4 Threat of Substitute Products
    • 3.4.5 Intensity of Competitive Rivalry

4 Latin America Cell Culture Market (by Product)

  • 4.1 Overview
  • 4.2 Consumables
    • 4.2.1 Cell Culture Reagents and Supplements
    • 4.2.2 Media
    • 4.2.3 Sera
    • 4.2.4 Plastic and Glass Consumables
  • 4.3 Instruments

5 Latin America Cell Culture Market (by End User)

  • 5.1 Overview
  • 5.2 Biotechnology and Life-Sciences Companies
  • 5.3 Pharmaceutical Companies
  • 5.4 Academic and Research Institutes

6 Latin America Cell Culture Market (by Country)

  • 6.1 Overview
  • 6.2 Brazil
  • 6.3 Mexico
  • 6.4 Argentina
  • 6.5 Chile
  • 6.6 Colombia
  • 6.7 Rest-of-Latin America

7 Company Profiles

  • 7.1 Overview
  • 7.2 Becton, Dickinson and Company
    • 7.2.1 Company Overview
    • 7.2.2 Role of Becton, Dickinson and Company in the Latin America Cell Culture Market
    • 7.2.3 Financials
    • 7.2.4 Key Insights about Financial Health of the Company
    • 7.2.5 SWOT Analysis
  • 7.3 CellGenix GmbH
    • 7.3.1 Company Overview
    • 7.3.2 Role of CellGenix GmbH in the Latin America Cell Culture Market
    • 7.3.3 SWOT Analysis
  • 7.4 Corning Incorporated
    • 7.4.1 Company Overview
    • 7.4.2 Role of Corning Incorporated in the Latin America Cell Culture Market
    • 7.4.3 Financials
    • 7.4.4 Key Insights about Financial Health of the Company
    • 7.4.5 SWOT Analysis
  • 7.5 Eppendorf AG
    • 7.5.1 Company Overview
    • 7.5.2 Role of Eppendorf AG in the Latin America Cell Culture Market
    • 7.5.3 Financials
    • 7.5.4 Key Insights about Financial Health of the Company
    • 7.5.5 SWOT Analysis
  • 7.6 Fujifilm Holdings Corporation
    • 7.6.1 Company Overview
    • 7.6.2 Role of Fujifilm Holdings Corporation in the Latin America Cell Culture Market
    • 7.6.3 Financials
    • 7.6.4 Key Insights about Financial Health of the Company
    • 7.6.5 SWOT Analysis
  • 7.7 General Electric Company
    • 7.7.1 Company Overview
    • 7.7.2 Role of General Electric Company in the Latin America Cell Culture Market
    • 7.7.3 Financials
    • 7.7.4 Key Insights about Financial Health of the Company
    • 7.7.5 SWOT Analysis
  • 7.8 Lonza Group AG
    • 7.8.1 Company Overview
    • 7.8.2 Role of Lonza Group AG in the Latin America Cell Culture Market
    • 7.8.3 Financials
    • 7.8.4 Key Insights about Financial Health of the Company
    • 7.8.5 SWOT Analysis
  • 7.9 Merck KGaA
    • 7.9.1 Company Overview
    • 7.9.2 Role of Merck KGaA in the Latin America Cell Culture Market
    • 7.9.3 Financials
    • 7.9.4 Key Insights about Financial Health of the Company
    • 7.9.5 SWOT Analysis
  • 7.10 Sartorius AG
    • 7.10.1 Company Overview
    • 7.10.2 Role of Sartorius AG in the Latin America Cell Culture Market
    • 7.10.3 Financials
    • 7.10.4 Key Insights about Financial Health of the Company
    • 7.10.5 SWOT Analysis
  • 7.11 Thermo Fisher Scientific Inc.
    • 7.11.1 Company Overview
    • 7.11.2 Role of Thermo Fisher Scientific Inc. in the Latin America Cell Culture Market
    • 7.11.3 Financials
    • 7.11.4 Key Insights about Financial Health of the Company
    • 7.11.5 SWOT Analysis

8 Research Scope and Methodology

  • 8.1 Report Scope
  • 8.2 Latin America cell culture market: Research Methodology

List of Tables

  • Table 2.1: Impact Analysis of Market Drivers
  • Table 2.2: Impact Analysis of Market Restraints

List of Figures

  • Figure 1: Impact of Market Drivers and Market Restraints on the Latin America Cell Culture Market
  • Figure 2: Latin America Cell Culture Market Snapshot
  • Figure 3: Dominating Segments of the Latin America Cell Culture Market, 2017 and 2025
  • Figure 4: Latin America Cell Culture Market (by Product), 2017 and 2025
  • Figure 5: Latin America Cell Culture Market (by End User), 2017 and 2025
  • Figure 6: Latin America Cell Culture Market (by Country), 2017 and 2025
  • Figure 1.1: Evolution of Cell Culture
  • Figure 1.2: Classification of Latin America Cell Culture Market
  • Figure 1.3: Latin America Cell Culture Market, 2017-2025
  • Figure 2.1: Iceberg Analysis for Latin America Cell Culture Market
  • Figure 2.2: Number of Deaths by Communicable Diseases, 2016
  • Figure 2.3: Current Initiatives in Latin America (as of 2015)
  • Figure 2.4: Percentage of Adults (25-64-year-olds) with Educational Attainment in Latin America (2017)
  • Figure 2.5: Drivers for Increasing Acceptance of 3D Cell Culture Systems
  • Figure 3.1: Share of Key Developments and Strategies, January 2015 - January 2019
  • Figure 3.2: Share of Product Launches and Enhancements, January 2015 - January 2019
  • Figure 3.3: Share of Synergistic Activities, January 2015 - January 2019
  • Figure 3.4: Market Share Analysis for the Latin America Cell Culture Market, 2017
  • Figure 3.5: Market Share Analysis for the Latin America Cell Culture Market, 2018
  • Figure 3.6: Growth Share Matrix (Opportunity Mapping) for Latin America Cell Culture Market (by Companies), 2018
  • Figure 3.7: Overall Industry Attractiveness, 2018 and 2025
  • Figure 3.8: Overall Impact of Bargaining Power of Suppliers
  • Figure 3.9: Overall Impact of Bargaining Power of Buyers
  • Figure 3.10: Overall Impact of Threat of New Entrants
  • Figure 3.11: Overall Impact of Threat of Substitute Products
  • Figure 3.12: Overall Impact of Intensity of Competitive Rivalry
  • Figure 4.1: Latin America Cell Culture Market (by Product)
  • Figure 4.2: Latin America Cell Culture Market (by Product), 2017 and 2025
  • Figure 4.3: Latin America Cell Culture Market (by Consumables), 2017-2025
  • Figure 4.4: Latin America Cell Culture Market (by Types of Consumables), 2017-2025
  • Figure 4.5: Latin America Cell Culture Market (by Types of Cell Culture Reagents and Supplements), 2017-2025
  • Figure 4.6: Latin America Cell Culture Market (by Types of Media), 2017-2025
  • Figure 4.7: Latin America Cell Culture Market (by Sera), 2017-2025
  • Figure 4.8: Latin America Cell Culture Market (by Plastic and Glass Consumables), 2017-2025
  • Figure 4.9: Latin America Cell Culture Market (by Instruments), 2017-2025
  • Figure 4.10: Latin America Cell Culture Market (by Types of Instruments), 2017-2025
  • Figure 5.1: Latin America Cell Culture Market (by End User)
  • Figure 5.2: Latin America Cell Culture Market (by End User), 2017 and 2025
  • Figure 5.3: Latin America Cell Culture Market (by Biotechnology and Life-Sciences Companies), 2017-2025
  • Figure 5.4: Latin America Cell Culture Market (by Pharmaceutical Companies), 2017-2025
  • Figure 5.5: Latin America Cell Culture Market (by Academic and Research Institutes), 2017-2025
  • Figure 6.1: Latin America Cell Culture Market (by Country)
  • Figure 6.2: Latin America Cell Culture Market (by Country), 2017 and 2025
  • Figure 6.3: Brazil Cell Culture Market, 2017-2025
  • Figure 6.4: Mexico Cell Culture Market, 2017-2025
  • Figure 6.5: Argentina Cell Culture Market, 2017-2025
  • Figure 6.6: Chile Cell Culture Market, 2017-2025
  • Figure 6.7: Colombia Cell Culture Market, 2017-2025
  • Figure 6.8: Rest-of-Latin America Cell Culture Market, 2017-2025
  • Figure 7.1: Total Number of Companies Profiled
  • Figure 7.2: Becton, Dickinson and Company: Overall Product Portfolio
  • Figure 7.3: Becton, Dickinson and Company: Overall Financials, 2016-2018
  • Figure 7.4: Becton, Dickinson and Company: Revenue (by Segment), 2016-2018
  • Figure 7.5: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2016-2018
  • Figure 7.6: Becton, Dickinson and Company: Revenue (by Region), 2016-2018
  • Figure 7.7: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
  • Figure 7.8: Becton, Dickinson and Company: SWOT Analysis
  • Figure 7.9: CellGenix GmbH: Overall Product Portfolio
  • Figure 7.10: CellGenix GmbH: SWOT Analysis
  • Figure 7.11: Corning Incorporated: Overall Product Portfolio
  • Figure 7.12: Corning Incorporated: Overall Financials, 2016-2018
  • Figure 7.13: Corning Incorporated: Revenue (by Segments), 2016-2018
  • Figure 7.14: Corning Incorporated: Revenue (by Region), 2016-2018
  • Figure 7.15: Corning Incorporated: R&D Expenditure, 2016-2018
  • Figure 7.16: Corning Incorporated: SWOT Analysis
  • Figure 7.17: Eppendorf AG: Overall Product Portfolio
  • Figure 7.18: Eppendorf AG: Overall Financials, 2015-2017
  • Figure 7.19: Eppendorf AG: Revenue (by Region), 2015-2017
  • Figure 7.20: Eppendorf AG: R&D Expenditure, 2015-2017
  • Figure 7.21: Eppendorf AG: SWOT Analysis
  • Figure 7.22: Fujifilm Holdings Corporation: Overall Product Portfolio
  • Figure 7.23: Fujifilm Holdings Corporation: Overall Financials, 2015-2017
  • Figure 7.24: Fujifilm Holdings Corporation: Revenue (by Segment), 2015-2017
  • Figure 7.25: Fujifilm Holdings Corporation: Revenue (by Region), 2015-2017
  • Figure 7.26: Fujifilm Holdings Corporation: R&D Expenditure, 2015-2017
  • Figure 7.27: Fujifilm Holdings Corporation: SWOT Analysis
  • Figure 7.28: General Electric Company: Overall Product Portfolio
  • Figure 7.29: General Electric Company: Overall Financials, 2016-2018
  • Figure 7.30: General Electric Company - Revenue (by Segment), 2016-2018
  • Figure 7.31: General Electric Company (GE Healthcare) - Revenue (by Segment), 2016-2018
  • Figure 7.32: General Electric Company: Revenue (by Region), 2016-2018
  • Figure 7.33: General Electric Company (GE Healthcare): Revenue (by Region), 2016-2018
  • Figure 7.34: General Electric Company: R&D Expenditure, 2016-2018
  • Figure 7.35: General Electric Company: SWOT Analysis
  • Figure 7.36: Lonza Group AG: Overall Product Portfolio
  • Figure 7.37: Lonza Group AG: Overall Financials, 2016-2018
  • Figure 7.38: Lonza Group AG: Revenue (by Segment), 2016-2018
  • Figure 7.39: Lonza Group AG: Revenue (by Region), 2016-2018
  • Figure 7.40: Lonza Group AG: R&D Expenditure, 2016-2018
  • Figure 7.41: Lonza Group AG: SWOT Analysis
  • Figure 7.42: Merck KGaA: Overall Product Portfolio
  • Figure 7.43: Merck KGaA: Overall Financials, 2016-2018
  • Figure 7.44: Merck KGaA: Revenue (by Segment), 2016-2018
  • Figure 7.45: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 7.46: Merck KGaA: Life Science Segment Revenue (by Region), 2016-2018
  • Figure 7.47: Merck KGaA: R&D Expenditure, 2016-2018
  • Figure 7.48: Merck KGaA: SWOT Analysis
  • Figure 7.49: Sartorius AG: Overall Product Portfolio
  • Figure 7.50: Sartorius AG: Overall Financials, 2016-2018
  • Figure 7.51: Sartorius AG: Revenue (by Segment), 2016-2018
  • Figure 7.52: Sartorius AG: Revenue (by Region), 2016-2018
  • Figure 7.53: Sartorius AG: R&D Expenditure, 2016-2018
  • Figure 7.54: Sartorius AG: SWOT Analysis
  • Figure 7.55: Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • Figure 7.56: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 7.57: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
  • Figure 7.58: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 7.59: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 7.60: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 8.1: Latin America Cell Culture Market Segmentation
  • Figure 8.2: Latin America Cell Culture Market Research Methodology
  • Figure 8.3: Primary Research
  • Figure 8.4: Secondary Research
  • Figure 8.5: Data Triangulation
  • Figure 8.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure 8.7: Top-down Approach (Segment-wise Analysis)
  • Figure 8.8: Assumptions and Limitations
  • Figure 8.9: Considered Factors for Data Prediction and Modelling
Back to Top